View in EDS

Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children.

Saved in:
Bibliographic Details
Title: Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children.
Authors: Martins RM; Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Maia MLS; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil., Camacho LAB; National School of Public Health, Fiocruz, Brazil., Noronha TG; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil., von Doellinger VR; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil., Santos AP; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil., Figueira ES; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil., Leal ML; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil., Jessouroun E; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil. Electronic address: ellen@bio.fiocruz.br.
Source: Vaccine [Vaccine] 2025 Aug 13; Vol. 61, pp. 127363. Date of Electronic Publication: 2025 Jun 09.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Clinical Trial, Phase III
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40494223
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martins+RM%22">Martins RM</searchLink>; Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Maia+MLS%22">Maia MLS</searchLink>; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22Camacho+LAB%22">Camacho LAB</searchLink>; National School of Public Health, Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22Noronha+TG%22">Noronha TG</searchLink>; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22von+Doellinger+VR%22">von Doellinger VR</searchLink>; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22Santos+AP%22">Santos AP</searchLink>; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22Figueira+ES%22">Figueira ES</searchLink>; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22Leal+ML%22">Leal ML</searchLink>; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil.<br /><searchLink fieldCode="AU" term="%22Jessouroun+E%22">Jessouroun E</searchLink>; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil. Electronic address: ellen@bio.fiocruz.br.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2025 Aug 13; Vol. 61, pp. 127363. <i>Date of Electronic Publication: </i>2025 Jun 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40494223
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2025.127363
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 127363
    Titles:
      – TitleFull: Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martins RM
      – PersonEntity:
          Name:
            NameFull: Maia MLS
      – PersonEntity:
          Name:
            NameFull: Camacho LAB
      – PersonEntity:
          Name:
            NameFull: Noronha TG
      – PersonEntity:
          Name:
            NameFull: von Doellinger VR
      – PersonEntity:
          Name:
            NameFull: Santos AP
      – PersonEntity:
          Name:
            NameFull: Figueira ES
      – PersonEntity:
          Name:
            NameFull: Leal ML
      – PersonEntity:
          Name:
            NameFull: Jessouroun E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 08
              Text: 2025 Aug 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 61
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1